Camber Capital Management LP Biogen Inc. Transaction History

Camber Capital Management LP

$4.08 Billion
Q1 2024

A detailed history of Camber Capital Management LP transactions in Biogen Inc. stock. As of the latest transaction made, Camber Capital Management LP holds 400,000 shares of BIIB stock, worth $92.7 Million. This represents 2.11% of its overall portfolio holdings.

Number of Shares

400,000

Holding current value

$92.7 Million

% of portfolio

2.11%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$212.02 - $267.71 $84.8 Million - $107 Million	400,000 New	400,000 $86.3 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $14.6 Million - $20.1 Million	75,000 Added 60.0%	200,000 $53.4 Million
Q2 2022 Aug 15, 2022	BUY	$187.54 - $223.02 $23.4 Million - $27.9 Million	125,000 New	125,000 $25.5 Million
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $48.4 Million - $61 Million	-250,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $39.2 Million - $50.4 Million	175,000 Added 233.33%	250,000 $60 Million

Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $21.2 Million - $27.7 Million	75,000 New	75,000 $21.2 Million
Q1 2021 May 17, 2021	SELL	$242.95 - $284.63 $48.6 Million - $56.9 Million	-200,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $47.3 Million - $71.1 Million	200,000 New	200,000 $49 Million
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $51.7 Million - $68.5 Million	-200,000 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $40.3 Million - $51.2 Million	-150,000 Reduced 42.86%	200,000 $63.3 Million
Q3 2019 Nov 14, 2019	BUY	$217.44 - $243.88 $76.1 Million - $85.4 Million	350,000 New	350,000 $81.5 Million
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $87.7 Million - $96.7 Million	-400,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $32.5 Million - $50.8 Million	150,000 Added 60.0%	400,000 $94.6 Million
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $13.9 Million - $17.6 Million	-50,000 Reduced 16.67%	250,000 $75.2 Million
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $44 Million - $57.6 Million	-150,000 Reduced 33.33%	300,000 $106 Million
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $16.7 Million - $19.9 Million	-65,000 Reduced 12.62%	450,000 $131 Million
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $134 Million - $189 Million	515,000 New	515,000 $141 Million

Others Institutions Holding BIIB

# of Institutions

1,046

Shares Held

126M

Call Options Held

1.37M

Put Options Held

1.35M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $33.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Camber Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Camber Capital Management LP with notifications on news.

Account

Camber Capital Management LP Biogen Inc. Transaction History